Regencell Bioscience Holdings (RGC) Interest Expenses (2020 - 2025)

Regencell Bioscience Holdings' Interest Expenses history runs 6 years deep, the most recent figure standing at $29931.0 for Q2 2025.

• Quarterly Interest Expenses fell 99.14% year-over-year to $29931.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $29931.0 (down 99.14% YoY) and the FY2025 annual result came in at $4.1 million, up 17.05% from the prior year.
• Interest Expenses was $29931.0 for Q2 2025 at Regencell Bioscience Holdings, down from $3.5 million in the prior quarter.
• Across five years, Interest Expenses topped out at $3.5 million in Q2 2024 and bottomed at $29931.0 in Q2 2025.
• A 5-year average of $1.8 million and a median of $1.9 million in 2022 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2022 — Interest Expenses surged 189.96% — and 2025, when it tumbled 99.14%.
• Regencell Bioscience Holdings' Interest Expenses stood at $659669.0 in 2021, then jumped by 189.96% to $1.9 million in 2022, then soared by 52.3% to $2.9 million in 2023, then advanced by 19.09% to $3.5 million in 2024, then tumbled by 99.14% to $29931.0 in 2025.
• Business Quant data shows RGC's Interest Expenses at $29931.0 in Q2 2025, $3.5 million in Q2 2024, and $2.9 million in Q2 2023.